Shiwen Peng
Shiwen Peng
aDepartment of Pathology, The Johns Hopkins University, Baltimore, Maryland, USA
a,
Deyin Xing
Deyin Xing
aDepartment of Pathology, The Johns Hopkins University, Baltimore, Maryland, USA
a,
Louise Ferrall
Louise Ferrall
aDepartment of Pathology, The Johns Hopkins University, Baltimore, Maryland, USA
a,
Ya-Chea Tsai
Ya-Chea Tsai
aDepartment of Pathology, The Johns Hopkins University, Baltimore, Maryland, USA
a,
Richard B S Roden
Richard B S Roden
aDepartment of Pathology, The Johns Hopkins University, Baltimore, Maryland, USA
bDepartment of Oncology, The Johns Hopkins University, Baltimore, Maryland, USA
cDepartment of Obstetrics and Gynecology, The Johns Hopkins University, Baltimore, Maryland, USA
a,b,c,
Chien-Fu Hung
Chien-Fu Hung
aDepartment of Pathology, The Johns Hopkins University, Baltimore, Maryland, USA
bDepartment of Oncology, The Johns Hopkins University, Baltimore, Maryland, USA
cDepartment of Obstetrics and Gynecology, The Johns Hopkins University, Baltimore, Maryland, USA
a,b,c,
T-C Wu
T-C Wu
aDepartment of Pathology, The Johns Hopkins University, Baltimore, Maryland, USA
bDepartment of Oncology, The Johns Hopkins University, Baltimore, Maryland, USA
cDepartment of Obstetrics and Gynecology, The Johns Hopkins University, Baltimore, Maryland, USA
a,b,c,✉
aDepartment of Pathology, The Johns Hopkins University, Baltimore, Maryland, USA
bDepartment of Oncology, The Johns Hopkins University, Baltimore, Maryland, USA
cDepartment of Obstetrics and Gynecology, The Johns Hopkins University, Baltimore, Maryland, USA
T.-C. Wu and Richard B. S. Roden are cofounders of and have an equity ownership interest in Papivax LLC. Also, both own Papivax Biotech, Inc., stock and are members of the Scientific Advisory Board of Papivax Biotech, Inc. All other authors declare no conflict of interest.
Collection date 2022 Mar-Apr.